Roche Targets Over 40% Diabetes Market Share Through R&D Investments
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics is concentrating its $150 mil. diabetes R&D budget on integrated management systems such as continuous strips, lancing strips and measuring needles for blood glucose testing
You may also be interested in...
Animas Upgrades Complaint Handling Program After Warning Letter
Animas says it has improved its complaint handling and corrective and preventive action programs substantially since receiving an FDA warning letter in February
Animas Upgrades Complaint Handling Program After Warning Letter
Animas says it has improved its complaint handling and corrective and preventive action programs substantially since receiving an FDA warning letter in February
Disetronic Swiss Facility QS Problems Draw Warning Letter, Import Alert
Roche Diagnostics is working with FDA to resolve quality systems issues uncovered at the Burgdorf, Switzerland facility of recently acquired insulin pump maker Disetronic Medical Systems